Canada Goose Announces Participation in Goldman Sachs 32nd Annual Global Retailing Conference — Neutral
GOOS Business Wire — August 27, 2025TORONTO--(BUSINESS WIRE)--Canada Goose Holdings Inc. (NYSE, TSX: GOOS) today announced that it will participate in the Goldman Sachs 32nd Annual Global Retailing Conference being held at the Conrad New York Downtown hotel in New York on September 3, 2025. We will host a fireside chat presentation at 3:15 pm ET and participate in one-on-one meetings. Beth Clymer, President, Chief Operating Officer and Neil Bowden, Chief Financial Officer will attend the conference. The fireside chat presentation.
Verastem Oncology to Present at Upcoming Investor Conferences — Neutral
VSTM Business Wire — August 27, 2025BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to participate and present at the following investor conferences in September: Cantor Global Healthcare Conference 2025: Fireside chat on Wednesday, September 3 at 3:55 pm ET H.C. Wainwright 27th Annual Global Investment Conference: Fireside chat on Monday, September 8.
Kymera Therapeutics to Participate in Upcoming September Investor Conferences — Neutral
KYMR GlobeNewsWire — August 27, 2025WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events:
Axsome Therapeutics to Participate in Upcoming Investor Conferences — Neutral
AXSM GlobeNewsWire — August 27, 2025NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in September:
Sionna Therapeutics to Participate in Upcoming September Investor Conferences — Neutral
SION GlobeNewsWire — August 27, 2025WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will participate in fireside chats at the following upcoming investor events:
Photronics Reports Third Quarter Fiscal 2025 Financial Results — Neutral
PLAB GlobeNewsWire — August 27, 2025BROOKFIELD, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its third quarter of fiscal year 2025 ended August 3, 2025.
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences — Neutral
APLS GlobeNewsWire — August 27, 2025WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences:
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences — Neutral
FHTX GlobeNewsWire — August 27, 2025CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in Citi's 2025 Biopharma Back to School Summit, 2025 Wells Fargo Healthcare Conference, and Morgan Stanley 23rd Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn's Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference — Neutral
MCRB GlobeNewsWire — August 27, 2025CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright Global Investment Conference in New York City and will present a company overview at 3:00 p.m. ET on September 8, 2025.
Avalo Therapeutics to Participate in Upcoming Investor Conferences — Neutral
AVTX GlobeNewsWire — August 27, 2025WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:
Bench IQ Raises $5.3 Million Seed Round to Arm Litigators with AI-Driven Intel on Judges — Neutral
INTC Business Wire — August 27, 2025TORONTO--(BUSINESS WIRE)--Bench IQ, the AI-powered judicial intelligence platform used by the world's top law firms, today announced it has raised a $5.3 million seed round led by Battery Ventures and Inovia Capital, with participation from CIBC Innovation Banking, MVP Ventures, Maple VC and Haystack VC. The new funding will fuel Bench IQ's growth, with a focus on expanding its proprietary dataset, advancing its AI agents, and expanding the team in the U.S. and Canada. Leading AmLaw 200 law fir.
U.S. GoldMining Advances 2025 Exploration Program Targeting Continued Growth at the District Scale Whistler Gold-Copper Project, Alaska — Neutral
USGO PRNewsWire — August 27, 2025ANCHORAGE, Alaska , Aug. 27, 2025 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce that it is well underway with exploration at its 100% owned Whistler Gold-Copper Project (the "Whistler Project" or "Project") for the 2025 field season in Alaska. The program is focused on targeting continued growth through developing new drill targets at the Whistler Orbit and Muddy Creek prospect areas.
WATERLOO, ONTARIO / ACCESS Newswire / August 27, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) announced today that it has appointed software executive Barry Mainz to its Board of Directors. Mr. Mainz is a technology veteran with 30 years of experience in executive leadership, global sales, marketing, product-led growth, and product development.
HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy — Neutral
MRK Business Wire — August 27, 2025BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--HERTHENA-Breast04 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic HR+/HER2- Breast Cancer.
Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP) — Neutral
AMLX Business Wire — August 27, 2025CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP).
Vontier's Driivz Partners With ENAPI to Expand Global EV Roaming and Simplify Connectivity — Neutral
VNT Business Wire — August 27, 2025RALEIGH, N.C.--(BUSINESS WIRE)--Driivz, a Vontier (NYSE: VNT) company and leading global software supplier to EV charging operators and service providers, today announced a partnership with ENAPI, a Berlin-based roaming connectivity platform, to deliver seamless, scalable EV charging across borders and networks, benefitting charge point operators (CPOs), e-mobility service providers (eMSPs), and EV drivers alike. This partnership unites the Driivz Smart EV Charging and Energy Management platfor.
The J.M. Smucker Co. Announces Fiscal 2026 First Quarter Results — Neutral
SJM PRNewsWire — August 27, 2025ORRVILLE, Ohio , Aug. 27, 2025 /PRNewswire/ -- The J.M. Smucker Co. (NYSE: SJM) today announced results for the first quarter ended July 31, 2025, of its 2026 fiscal year.
MINNEAPOLIS , Aug. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 2025 Wells Fargo Healthcare Conference September 3, 2025 10:15 AM EDT Baird 2025 Global Healthcare Conference September 9, 2025 9:05 AM EDT Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:45 AM EDT A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and …
MPLX LP to Divest Rockies Gathering and Processing Assets — Neutral
MPLX PRNewsWire — August 27, 2025FINDLAY, Ohio , Aug. 27, 2025 /PRNewswire/ -- MPLX LP (NYSE: MPLX) today announced it has entered into a definitive agreement to divest its Rockies gathering and processing assets to a subsidiary of Harvest Midstream for $1.0 billion in cash consideration, subject to customary purchase price adjustments. Harvest has contractually agreed to dedicate approximately 12 thousand barrels per day of NGLs from these assets to MPLX for a period of seven years commencing in 2028, following the expiration of a pre-existing commitment.
ECARX Receives ASPICE v4.0 CL3 Certification, Reinforcing Global Expansion and Technology Leadership — Neutral
ECX GlobeNewsWire — August 27, 2025SHANGHAI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ECARX (Nasdaq: ECX), a global mobility technology provider, today announced that its Antora® 1000 Pro computing platform has received Automotive SPICE (ASPICE) v4.0 Capability Level 3 (CL3) certification – the highest rating under the ASPICE standard. This adds to ECARX's growing portfolio of certifications - prerequisites for collaboration with leading automakers – and underscores its commitment to building a robust, fully compliant infrastructure as the foundation for its accelerated global expansion and continued innovation.